[Form 4] Celanese Corp Insider Trading Activity

Rhea-AI Filing Summary

Celanese Corp (CE) reported an equity award to a senior executive. A Form 4 filing shows that an officer serving as SVP & General Counsel received 6,624 shares of Celanese common stock on 11/17/2025 in the form of time-based restricted stock units granted under the company’s Amended and Restated 2018 Global Incentive Plan. The award was recorded at a price of $0 per share, reflecting that it is a compensatory grant rather than an open-market purchase.

Each RSU represents the right to receive one share of common stock, with vesting subject to continued employment. The RSUs will vest 50% on November 17, 2026 and the remaining 50% on November 17, 2027. After this grant, the reporting person directly beneficially owned 20,459 shares, and an additional 624.623 shares were held indirectly through a 401(k) plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duffie Ashley B

(Last) (First) (Middle)

C/O 222 W LAS COLINAS BLVD, SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & GC

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2025		A		6,624(1)	A	$0	20,459	D
Common Stock								624.623	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Time-based restricted stock units ("RSUs") granted pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest, subject to continued employment, with respect to 50% of the RSUs on each of November 17, 2026 and November 17, 2027.

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Ashley B. Duffie	11/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Celanese Corp (CE) report in this Form 4?

The filing reports that an officer of Celanese Corp (CE), serving as SVP & General Counsel, received 6,624 time-based restricted stock units of Celanese common stock on 11/17/2025 as an equity compensation grant.

What are the vesting terms of the 6,624 RSUs reported by Celanese (CE)?

The 6,624 time-based RSUs will vest, subject to continued employment, in two equal installments: 50% on November 17, 2026 and 50% on November 17, 2027, with each RSU converting into one share of common stock at vesting.

At what price were the Celanese (CE) RSUs granted in this Form 4?

The RSUs were reported with a grant price of $0 per share, indicating they are part of the company’s equity compensation and not purchased in the open market.

How many Celanese (CE) shares does the reporting person own after this RSU grant?

Following the reported transaction, the officer beneficially owned 20,459 shares of Celanese common stock directly, and an additional 624.623 shares were held indirectly through a 401(k) plan.

Under which plan were the Celanese (CE) RSUs granted?

The 6,624 RSUs were granted under Celanese’s Amended and Restated 2018 Global Incentive Plan, which governs the company’s equity-based compensation awards.

What role does the reporting person hold at Celanese Corp (CE)?

The reporting person is identified as an officer of Celanese Corp with the title SVP & General Counsel, indicating a senior executive and legal leadership position.